Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 4/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.53 |
| ▸ | MEN1 | O00255 | 3/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.53 |
| ▸ | CA1 | P00915 | 3/20 | 0.53 |
| ▸ | CA2 | P00918 | 3/20 | 0.53 |
| ▸ | TP53 | P04637 | 3/20 | 0.53 |
| ▸ | ADORA3 | P0DMS8 | 3/20 | 0.53 |
| ▸ | CA12 | O43570 | 2/20 | 0.53 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.53 |
| ▸ | AR | P10275 | 2/20 | 0.53 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.53 |
| ▸ | CA9 | Q16790 | 2/20 | 0.53 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.53 |
| ▸ | DDR2 | Q16832 | 1/20 | 0.53 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.53 |
| ▸ | PKM | P14618 | 1/20 | 0.53 |
| ▸ | ABCG2 | Q9UNQ0 | 3/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22960257 | 0.87 | CHRM2 (0.53) | KMT2ACYP3A4MEN1KDM4ELMNA | |
| SCHEMBL1534666 | 0.85 | KMT2A (0.65) | KMT2ACYP3A4MEN1KDM4ELMNA | |
| SCHEMBL29501080 | 0.85 | KMT2A (0.65) | KMT2ACYP3A4MEN1KDM4ELMNA | |
| SCHEMBL28356532 | 0.85 | LMNA (0.58) | KMT2ACYP3A4MEN1KDM4ELMNA | |
| SCHEMBL6825720 | 0.85 | MAPK14 (0.52) | KMT2ACYP3A4MEN1KDM4ELMNA | |
| SCHEMBL25824773 | 0.81 | PLA2G2A (0.47) | KMT2ACYP3A4MEN1KDM4ELMNA | |
| SCHEMBL28356499 | 0.81 | MEN1 (0.53) | KMT2ACYP3A4MEN1KDM4ELMNA | |
| SCHEMBL29316396 | 0.80 | KMT2A (0.46) | KMT2ACYP3A4MEN1KDM4ELMNA | |
| SCHEMBL25824780 | 0.78 | ANO1 (0.43) | KMT2ACYP3A4MEN1KDM4ETP53 | |
| SCHEMBL592430 | 0.77 | CA1 (0.55) | KMT2ACYP3A4MEN1KDM4ELMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023132488-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 주식회사 엘지화학 | 2023-07-13 | — | — | WO | disclosed |
| WO-2023121082-A1 | NOVEL ORGANIC LIGHT EMITTING DEVICE COMPRISING TWO LIGHT EMITTING LAYERS | 에스에프씨 주식회사 | 2023-06-29 | — | — | WO | disclosed |
| CN-110760877-B | Method for continuously preparing 2-aryl-3-halogenated-benzofuran compound by using electrochemical microchannel reaction device | 南京工业大学 | 2021-01-29 | — | — | CN | disclosed |
| CN-110760877-A | Method for continuously preparing 2-aryl-3-halogenated-benzofuran compound by using electrochemical microchannel reaction device | 南京工业大学 | 2020-02-07 | — | — | CN | disclosed |
| US-20070238740-A1 | Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use | NITROMED, INC. (US) | 2007-10-11 | — | — | US | disclosed |
| CN-1816553-A | Process for the preparation of furopyrroles | CIBA SC HOLDING AG (CH) | 2006-08-09 | — | — | CN | disclosed |
| WO-2004089939-A1 | CONDENSED FURAN DERIVATIVES AS ADENOSINE ANTAGONISTS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2004-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238740-A1 | Nitrosated And Nitrosylated Cardiovascular Compounds, Compositions And Methods Of Use | REN, ECE1, EDNRA | KMT2A 4254/4885CYP3A4 970/4885MEN1 1130/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.